Atlas Trials

Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Becker Muscular Dystrophy

Clinical trial NCT03238235 · COMPLETED

Trial details

NCT number
NCT03238235
Sponsor
Italfarmaco
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Becker Muscular Dystrophy
Start date
2018-01-09
Primary completion
2021-03-19
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.